Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11285190
CLEC11a is a bone growth agent
granted -
US 11278592
Methods and compositions for TUSC2 immunotherapy
granted -
US 11274282
Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen
granted -
US 11267832
Mn(II)-based sensors to detect zinc in vivo with MRI
granted -
US 11260073
Compounds and methods for modulating C90RF72
granted -
US 11246937
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 11247968
Lipocationic dendrimers and uses thereof
granted -
US 11229599
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted -
US 11230591
CMV neutralizing antigen binding proteins
granted -
US 11229609
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11224645
Glycoconjugate vaccine for leishmaniasis
granted -
US 11219633
Nucleobase analogue derivatives and their applications
granted -
US 11214595
BK channel-modulating peptides and their use
granted -
US 11213592
Antibody-sting agonist conjugates and their use in immunotherapy
granted -
US 11207322
Method and composition related to combination therapy for addiction
granted -
US 11208479
CX43 hemichannel antibodies and methods of use
granted -
US 11207329
Methods for treating GI syndrome and graft versus host disease
granted -
US 11207396
Immunization to protect against adverse cardiac events relating to pneumococcal infection
granted -
US 11197928
Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
granted -
US 11191750
Use of mTOR inhibitors for treatment of familial adenomatous polyposis
granted -
US 11192958
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted -
US 11191778
Multifunctional linker technology containing an N4 group
granted -
US 11185554
Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
granted -
US 11181520
Systems and methods for high-resolution imaging
granted